PRINCIPAL FINANCIAL GROUP INC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 76 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2016$4,000
-20.0%
15,3750.0%0.00%
Q4 2015$5,000
-81.5%
15,3750.0%0.00%
Q3 2015$27,000
-50.9%
15,375
-38.0%
0.00%
Q2 2015$55,000
+52.8%
24,785
+32.7%
0.00%
Q1 2015$36,000
-28.0%
18,681
-1.2%
0.00%
Q4 2014$50,000
-54.1%
18,906
-13.6%
0.00%
Q2 2013$109,00021,8710.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q4 2015
NameSharesValueWeighting ↓
CAXTON CORP 37,069,140$64,500,00087.00%
ARMISTICE CAPITAL, LLC 2,000,000$3,480,0001.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 432,259$752,0000.28%
Geller Advisors LLC 187,323$326,0000.21%
CAXTON CORP 57,000$99,0000.13%
Verity Asset Management, Inc. 64,476$112,0000.11%
TFS CAPITAL LLC 367,364$639,0000.06%
Cutler Capital Management, LLC 72,500$126,0000.06%
LUCAS CAPITAL MANAGEMENT 21,100$37,0000.02%
Nine Chapters Capital Management LLC 129,700$226,0000.02%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders